Stock Analiz

STE vs ZBH stock comparison

STERIS vs. Zimmer Biomet · data as of November 13, 2026

STERIS (STE) has a market value of about $25.7B, Zimmer Biomet (ZBH) about $19.5B. Over their latest twelve months STERIS had revenue of $6.2B and Zimmer Biomet $8.6B.

On our five checks STERIS scores higher: 3.0 out of 5 (average) against 2.2 (weak).

By area, the stronger company is Zimmer Biomet on value; STERIS on future growth; STERIS on track record; STERIS on financial health.

Zimmer Biomet is cheaper on earnings (P/E 26.1 vs. 31.4), while STERIS grew revenue faster over five years (13.8% vs. 6.1% a year).

STERIS leads on 11 of the compared lines and Zimmer Biomet on 11.

Side by side

STEZBH
Size and price
Market cap$25.7B$19.5B
Share price$264.32$103.21
Score
Overall score (of 5)3.02.2
Value01
Future growth21
Track record31
Financial health53
Shareholder returns55
Valuation
P/E (TTM)31.426.1
Forward P/E21.711.4
Price / free cash flow27.411.9
Price / sales4.22.3
EV / EBITDA16.211.7
PEG2.76—
DCF value vs. price−43%−12%
Business
Revenue$6.2B$8.6B
Net income$827M$767M
Free cash flow$937M$1.6B
Net margin13.4%9.0%
Gross margin (5-yr avg.)43.9%71.0%
ROIC (5-yr avg.)6.8%4.8%
Growth
Revenue growth (1 yr)8.7%7.2%
Revenue growth (5 yrs, per year)13.8%6.1%
EPS growth (5 yrs, per year)11.4%—
Balance sheet and payouts
Net cash (cash minus debt)-$1.4B-$7.1B
Dividend yield1.04%0.93%
Shareholder yield2.0%3.4%
Analysts
Upside to average target+6%+13%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: STE TTM to September 30, 2026, ZBH TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, STERIS or Zimmer Biomet?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) STERIS scores 3.0 out of 5 and Zimmer Biomet 2.2; the table shows where each one is stronger.

Is STERIS cheaper than Zimmer Biomet?

On trailing earnings, Zimmer Biomet trades at a P/E of 26.1 and STERIS at 31.4, so Zimmer Biomet is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, STERIS or Zimmer Biomet?

Over five years STERIS grew revenue about 13.8% a year and Zimmer Biomet about 6.1% a year.

Which pays a higher dividend?

STERIS yields 1.04% and Zimmer Biomet 0.93%.

Full STERIS analysis → Full Zimmer Biomet analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.